Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
105.63 USD  +0.66 (+0.63%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Amgen, Inc.
 
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Sector Round Up - Pharmaceuticals Declined: NVO, AZN, MRK
April 20, 2010
New York, April 20th (TradersHuddle.com) - At the half of the trading session tha market is trading higher with the S&P 500 adding 0.88%. Stocks of Pharmaceutical Companies are also trading higher,... Read More
from TradersHuddle.com
Consistent Cash Creators One Year Later
April 20, 2010
It has been over a year since I discussed my Consistent Cash Creators with High Normalized Earnings Yield screen. I developed this screen a few years ago in order to identify companies that have... Read More
category PH , DHR , ADBE , and 28 more.
from Fat Pitch Financials
This Week
April 20, 2010
from Wall Street Greek
Market Forecast + Sector Watch: SPX, Nasdaq, GLD, XME, XLF, INX2, QCOM, AMGN, EBAY, FFIV, SNDK, MEE, EMC, FCX, BA, MCD, AAPL, IBM, BTU, AMZN, MSFT, MDC, PCX
April 19, 2010
Last weekend, in my Market Forecast, I wrote: "For the new week, the help that eurozone governments have committed to Greece should inspire the market to a strong start.  We could easily see SPX 1200... Read More
category EMC , MEE , AMZN , and 18 more.
from Wang's Happy Trading
A Gold Star for Amgen…
April 16, 2010
When it’s time to make executive compensation decisions, companies seek input from several sources. Those usually include the Compensation committee, the executives themselves, and outside consulting... Read More
category odd filings , Gold Stars , proxy
from footnoted*
(AMGN) Amgen to Attend American Association for Cancer Research Meeting
April 14, 2010
Amgen Inc. (AMGN) should have a strong presence at the upcoming annual meeting of the American Association for Cancer Research (AACR) where the company intends to present preclinical data on its... Read More
category Biotechnology , LLY , Amgen Inc , and 5 more.
from Stock Blog Hub
Long-Term Trader Opens a Bullish Spread on Amgen, Inc.
April 12, 2010
Can Amgen, Inc. (AMGN) tackle stubborn resistance at the %2465 level during the long term? One speculator seems to think so, since the drug company was the target of a massive call spread earlier... Read More
category AMGN
from SchaeffersResearch.com Trading Floor Blog
Opportunity in Health Care Crisis
March 27, 2010
Wealth Daily Editor Ian Cooper takes a look back at the week in the financial arena, and tells readers how to turn quick profits from health care reform. Read More
from Wealth Daily
Monsanto (MON)– Sowing Future Profits
March 26, 2010
Monsanto (MON, News, Press Releases: 71.49 +0.24 +0.34%, yield: 1.49, cap: 39.010B, 1yr target: 91.27) is the world’s leading producer of seeds. Their seed and genomics division combines advanced... Read More
category MON , agricultural , crops , and 15 more.
from CEOWORLD Magazine
Amgen near Resistance
March 18, 2010
New York, March 18th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated resistance at $59.42 with the current price action closing at just $57.43 placing the... Read More
from TradersHuddle.com
(GSK) GlaxoSmithKline Drug Gets European Commission Approval
March 16, 2010
GlaxoSmithKline Plc. (GSK) recently received good news in the form of European approval for its oral thrombopoetin agonist, Revolade (eltrombopag). The European Commission (EC) granted marketing... Read More
category Amgen Inc , Glaxosmithkline plc , Ligand Pharmaceuticals Inc , and 5 more.
from Stock Blog Hub
GSK Drug Gets EC Approval
March 15, 2010
GlaxoSmithKline Plc. (NYSE:GSK) recently received good news in the form of European approval for its oral thrombopoetin agonist, Revolade (eltrombopag). The European Commission (EC) granted marketing... Read More
category LGND , External Research , Contributor , and 6 more.
from DailyMarkets.com
Amgen (AMGN)– A Profitable Biotech at a Bargain Price
March 15, 2010
Amgen Inc. (AMGN, News, Press Releases: 56.78 -0.65 -1.13%, yield: N/A, cap: 55.605B, 1yr target: 68.76) is the world’s largest independent biotechnology medicines company. They discover, develop,... Read More
category Tech and Web , human therapeutics , biotechnology , and 4 more.
from CEOWORLD Magazine
Amgen near Resistance
March 12, 2010
New York, March 12th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated resistance at $59.42 with the current price action closing at just $57.49 placing the... Read More
from TradersHuddle.com
Investing in the Biotechnology Industry
March 11, 2010
Wealth Daily Editor Steve Christ takes a look at three of latest deals in the biotechnology sector and explains why they are just the tip of the iceberg. Read More
from Wealth Daily
Amgen Near Important Moving Averages
March 09, 2010
New York, March 9th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) closed the trading session at $57.76 near its 50 day and 200 day moving averages currently set at $57.13 and $56.96... Read More
from TradersHuddle.com
Oil (USO) Headed Lower on Technicals – Bearish Engulfing
March 09, 2010
We have been watching oil closely over the past few weeks as the breakout and breakdown pattern has been providing for a good deal of profit opportunities. Now it appears that it is close to a topping... Read More
category commodities , Short Ideas , Stocks , and 2 more.
from Disciplined Investor
Amgen Closing in to Resistance
March 04, 2010
New York, March 4th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated resistance at $59.42 with the current price action closing at just $56.90 placing the... Read More
from TradersHuddle.com
Biotech Update: Astellas Targets OSI Pharmaceuticals
March 01, 2010
The tip of the iceberg... Read More
from Wealth Daily
Market Forecast + Sector Watch: SPX, Nasdaq, UUP, GLD, XLF, BTK, AIG, AET, UNH, SLXP, NUVA, CELG, AMGN, OSIP, GENZ, PRU
February 28, 2010
Last weekend, in my Market Forecast, I said, "For the new week, as mentioned last weekend, SPX 1120 will be the nearest resistance.  The market has rallied quite far.  Unless, there are really positive... Read More
category AIG , PRU , CELG , and 11 more.
from Wang's Happy Trading
(AMGN) Amgen Awaits US Food and Drug Administration Action on Osteoporosis Drug Candidate
February 24, 2010
The US Food and Drug Administration (FDA) recently accepted Amgen, Inc.’s (AMGN) complete response submission for Prolia, the company’s lead pipeline candidate, and established an action date of Jul... Read More
category Amgen Inc , Biotechnology , Healthcare , and 1 more.
from Stock Blog Hub
Amgen’s Date With The FDA
February 22, 2010
The US Food and Drug Administration (FDA) recently accepted Amgen, Inc.’s (NASDAQ:AMGN) complete response submission for Prolia, the company’s lead pipeline candidate, and established an action date of... Read More
category USA , AMGN , Stocks , and 3 more.
from DailyMarkets.com
Market Forecast + Sector Watch + Weekly Wrap: SPX, Nasdaq, UUP, GLD, USO, BTK
February 21, 2010
Last weekend, in my Market Forecast, I wrote: "For the new week, if SPX can push above 1080, the market could rally higher to test 1100.  Above 1100, 1120 is the next resistance.  Tech stocks should... Read More
category RIMM , AMZN , TEVA , and 13 more.
from Wang's Happy Trading
(AMGN) Amgen and Johnson & Johnson See More Safety Check of Anemia Drugs
February 17, 2010
For quite some time, anemia drugs developed by Amgen (AMGN) and Johnson & Johnson (JNJ) have been under the US Food and Drug Administration (FDA) scanner. Recently, the agency announced a new safety... Read More
category Amgen Inc , Biotechnology , JNJ , and 3 more.
from Stock Blog Hub
More Checks For Anemia Drugs
February 17, 2010
For quite some time, anemia drugs developed by Amgen (AMGN) and Johnson and Johnson (JNJ) have been under the US Food and Drug Administration (FDA) scanner. Recently, the agency announced a new safety... Read More
category jnj , USA , AMGN , and 4 more.
from DailyMarkets.com
Amgen Close to Support
February 15, 2010
New York, Feb 15th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated support at $54.65 with current price action closing at just $56.48 places the stock... Read More
from TradersHuddle.com
(AMGN) Amgen Earns Positive Results From Phase III Drug Study
February 09, 2010
Amgen Inc. (AMGN) received a boost recently when the company announced positive results from a pivotal head-to-head phase III study that was conducted with Amgen’s main pipeline candidate, denosumab.... Read More
category NVS , Amgen Inc , Biotechnology , and 3 more.
from Stock Blog Hub
Positive Results On Amgen Drug « Zacks Investment Research »
February 09, 2010
Amgen Inc. (AMGN) received a boost recently when the company announced positive results from a pivotal head-to-head phase III study that was conducted with Amgen’s main pipeline candidate, denosumab.... Read More
category NVS , USA , AMGN , and 4 more.
from DailyMarkets.com
Approaching Resistance-Amgen
February 05, 2010
New York, feb 5th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated resistance at $59.42 with the current price action closing at just $57.53 placing the... Read More
from TradersHuddle.com
Amgen Breaking Out?
February 03, 2010
New York, jan 3rd (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) closed the trading session at $59.23 just above calculated resistance at $58.93 moving to what appears to be a new range, as... Read More
from TradersHuddle.com
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here